BridgeBio Oncology Therapeutics, Inc. (BBOT)

Distributing

Institutional distribution: ownership decreased -1.14% quarter-over-quarter.

Data as of Q1 2026

Institutional Ownership

71.74%

QoQ Change

-1.14%

Total Value

$509.5B

Shares Outstanding

80.0M

Crowding AnalysisCrowded

Holders66of 5,944

Avg: 68

Uncrowded84th percentileCrowded

Institutional Activity

Buy/Sell Ratio2.15x

65th percentile

43 buying20 selling

+23

New

-9

Closed

-872,572

Net shares

Holding Period Distribution

estimate

Median: 2 QAvg: 2.1 QHolders: 66

Ownership Concentration

Top 5: 55.2%Top 10: 76.5%

Cormorant Asset Management,31.1%

DEERFIELD MANAGEMENT COMPANY, L.P.8.5%

Omega Fund Management,5.7%

Alphabet4.9%

EcoR1 Capital,4.9%

Others (61)44.8%

Loading crowding analysis...

Conviction-Weighted Ownership

Median weight: 0.85%Avg weight: 3.66%Max: 18.05%High conviction (>1%): 5

Cormorant Asset Management,

DEERFIELD MANAGEMENT COMPANY, L.P.

Omega Fund Management,

Alphabet

EcoR1 Capital,

WELLINGTON MANAGEMENT GROUP LLP

Loading conviction analysis...

Whale Moves Timeline (2 Quarters)

Biggest dollar-value position changes among top 10 holders

NEWNovo Holdings A/S$20M2.2M shr

SOLDWELLINGTON MANAGEMENT GROUP LLP$793K89K shr

BOUGHTBlackRock$31K3K shr

SOLDCITADEL ADVISORS$14K2K shr

NEWParadigm Biocapital Advisors$28M2.3M shr

SOLDWELLINGTON MANAGEMENT GROUP LLP$679K54K shr

BOUGHTBlackRock$454K36K shr

SOLDCITADEL ADVISORS$98K8K shr

Loading whale moves...

Institutional Trends (3 Quarters)

Loading ownership trends...

Institutional Holders

Loading top holders...